Graham Steel, layman's Publications

Elina Zotova, James Nicoll, Raj Kalaria, Clive Holmes, Delphine Boche (2010) Inflammation in Alzheimer's disease: relevance to pathogenesis and therapy, 1. In Alzheimer's Research & Therapy 2 (1).

Jennifer C Schymick, Gabriella Restagno, Sonja W Scholz, Shiao-lin Lai, Gabriele Mora, Hon-Chung Fung, Angela Britton, J Raphael Gibbs, Michael Nalls, Stephen Berger, Lydia Coulter Kwee, Z Oddone, Jinhui Ding, Cynthia Crews, Ian Rafferty, Nicole Washecka, Luigi Ferrucci, Stefania Bandinelli, Jack Guralnik, Fabio Macciardi, Federica Torri, Sara Lupoli, Stephen J Chanock, Gilles Thomas, David J Hunter, Christian Gieger, Andrea Calvo, Roberto Mutani, Fabio Giannini, Claudia Caponnetto, Giovanni Luigi Mancardi, Vincenzo La, Francesca Valentino, Gioacchino Tedeschi, Mario Sabatelli, Amelia Conte, Jessica Mandrioli, Patrizia Sola, Ilaria Bartolomei, Gabriele Siciliano, Cecilia Carlesi, Richard W Orrell, Zachary Simmons, James Connor, Erik P Pioro, Travis Dunkley, Dietrich A., Dalia Kasperavičiūtė, Elizabeth M Fisher, Sibylle Jabonka, Michael Sendtner, Marcus Beck, Lucie Bruijn, Jeffrey Rothstein, Silke Schmidt, Andrew Singleton, Bryan J Traynor, Molecular Genetics Unit (2009) A two-stage genome-wide association study of sporadic amyotrophic lateral sclerosis, 1-28. In Neurological Sciences.

Matthew Bishop, Catherine Pennington, Craig Heath, Robert Will, Richard Knight (2009) PRNP variation in UK sporadic and variant Creutzfeldt Jakob disease highlights genetic risk factors and a novel non-synonymous polymorphism., 146. In BMC medical genetics 10 (1).

Supplementary Results, Supplementary Fig, Supplementary Methods, Quic (2008) -seeded conversion of ham- accumulation of a pathological, typically protease-resistant form ster rPrP-sen (residues 23–231) into PK-resistant conversion of prion protein, termed PrP, 211-212. In Nature Methods 5 (3).

Prion Disease Pathology Surveillance Center (2008) A New Prionopathy, 677-678. In Annals of Neurology.

Nigel M Hooper, Anthony J Turner (2008) A new take on prions: preventing Alzheimer’s disease, 1-5. In Trends in biochemical sciences.

Pierluigi Gambetti, Zhiqian Dong, Jue Yuan, Xiangzhu Xiao, Mengjie Zheng, Amer Alshekhlee, Rudy Castellani, Mark Cohen, Marcelo A Barria, Ermias D Belay, Lawrence B Schonberger, Karen Marder, Carrie Harris, James R Burke, Thomas Montine, Thomas Wisniewski, Dennis W Dickson, Claudio Soto, Christine M Hulette, James A Mastrianni, Qingzhong Kong, Wen-quan Zou (2008) A Novel Human Disease with Abnormal Prion Protein Sensitive to Protease, 697-708. In Annals of Neurology.

D Alastair, S Compston, United Kingdom, Stephen L Lake, Susan Moran, David H., Kim Norris, P K Tandon (2008) Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis. In October.

Paul Davies, Sarah N Fontaine, Dima Moualla, Xiaoyan Wang, Josephine A Wright, David R Brown (2008) Amyloidogenic metal-binding proteins: new investigative pathways, 1299-1303. In Biochemical Society Transactions.

Lesley A Stewart, Larysa H M Rydzewska, Geraldine F Keogh, Richard S G (2008) Downloaded from www.neurology.org at Harvard University on April 9, 2008. In Clinical Trials.

Shirley Hesketh, Judyth Sassoon, Robert Knight, David R Brown (2008) Elevated manganese levels in blood and CNS in human prion disease, 590 - 598. In Veterinary Research.

Meredith Wadman (2008) Elias Zerhouni looks back, 12-14. In Nature.

Fabienne Reine, Annick Le Dur, Hubert Laude (2008) Vincent Béringue, Laëtitia Herzog, Fabienne Reine, Annick Le Dur, Cristina Casalone, Jean-Luc Vilotte, and Hubert Laude, 12-15. In Emerging Infectious Diseases 14 (12).

Onur Sakarya, Kathryn A Armstrong, Maja Adamska, Marcin Adamski, I-Fan Wang, Bruce Tidor, Bernard M Degnan, Todd H (2007) A Post-Synaptic Scaffold at the Origin of the Animal Kingdom. In America.

Tom Birger Granström, Ken Izumori, Matti Leisola (2007) A rare sugar xylitol. Part I: the biochemistry and biosynthesis of xylitol, 273-276. In Journal of Applied Microbiology.

Sharon F Terry, Patrick F Terry, Katherine A Rauen, Jouni Uitto, Lionel G Bercovitch (2007) Advocacy groups as research organizations: the PXE International example, 157-164. In Genetics 8 (February).

Jeremy E Turnbull, Robert A Field (2007) Emerging glycomics technologies, 74-77. In Nature Chemical Biology 3 (2).

Joseph A Vandello, Nadav P Goldschmied, David A R Richards (2007) Personality and Social Psychology Bulletin. In Social Psychology.

Makoto Yanagisawa, Robert K Yu (2007) REVIEW The expression and functions of glycoconjugates in neural stem cells. In Access 17 (7).

Joel C Watts, Bettina Drisaldi, Vivian Ng, Jing Yang, Bob Strome, Patrick Horne, Man-sun Sy, Larry Yoong, Rebecca Young, Peter Mastrangelo, Catherine Bergeron, Paul E Fraser, George A Carlson, Gerold Schmitt-ulms, David Westaway (2007) The CNS glycoprotein Shadoo has PrP -like protective properties and displays reduced levels in prion infections, 1-13. In Molecular Biology.

William C Lamanna, Ina Kalus, Michael Padva, Rebecca J Baldwin, Catherine L R Merry, Thomas Dierks (2007) The heparanome—The enigma of encoding and decoding heparan sulfate sulfation, 290-307. In Journal of Biotechnology.

Zhongcong Xie, Yuanlin Dong, Uta Maeda, Robert D Moir, Weiming Xia, Deborah J Culley, Gregory Crosby, Rudolph E Tanzi (2007) The Inhalation Anesthetic Isoflurane Induces a Vicious Cycle of Apoptosis and Amyloid ␤ -Protein Accumulation, 1247-1254. In Neurobiology of Disease 27 (6).

Thierry Baron, Anna Bencsik, Anne-gaëlle Biacabe Eric, Richard A Bessen (2007) Thierry Baron,* Anna Bencsik,* Anne-Gaëlle Biacabe,* Eric Morignat,* and Richard A. Bessen†, 1887-1894. In Emerging Infectious Diseases 13 (12).

(2007) University Publishing In A Digital Age. In Director.

La Jolla, German Cancer Research Centre (2007) White Paper Report from Focus Groups at the NIH Workshop on Frontiers in Glycomics and Glycobiology (8, 1-25. In Biomarkers.

Karolinska Hospital, Frida Kasteng, N Wilking, B Jo (2007) ª 2007, 1-78. In Annals of Oncology 18 (Supplement 3).

J B C Papers (2006) 1 heparan sulfate-related oligosaccharides in ternary complex formation with fibroblast growth factors 1 and 2 and their receptors. In Science.

The Editorial, Brief, Hot Topic, The Quest, Pre-clinical Blood Screening Test (2006) 5, April 2006. In Communication.

David A Kocisko, Winslow S Caughey, Richard E Race, Grant Roper, Byron Caughey, John D Morrey (2006) A Porphyrin Increases Survival Time of Mice after Intracerebral Prion Infection, 759-761. In Microbiology 50 (2).

T Satoh, J Cui, Y Watanabe, K Furuta, M Suzuki, K Tohyama, S A Lipton (2006) Activation of the Keap1͞Nrf2 pathway for neuroprotection by electrophillic phase II inducers, 1-6.

Jill Mcvee, Janet M Bradshaw Mpcpath, Geoffrey R Pearson Bvms, Elizabeth Head, Francis J Gunn-moore (2006) Ageing changes in cat brains demonstrated by, 234-242. In Epidemiology.

David S Wishart, Craig Knox, An Chi Guo, Savita Shrivastava, Murtaza Hassanali, Paul Stothard, Zhan Chang, Jennifer Woolsey (2006) DrugBank: a comprehensive resource for in silico drug discovery and exploration, 668-672. In Nucleic Acids Research.

Karen Vana (2006) The 37 kDa/67 kDa laminin receptor as a therapeutic target in prion diseases: potency of antisense LRP RNA, siRNAs specific for LRP mRNA and a LRP decoy mutant.

(2006) The Access Principle. In Electronic Publishing.

Stefano Colacino, Guido Tiana, Ricardo A Broglia, Giorgio Colombo, Sezione Milano (2006) The Determinants of Stability in the Human Prion Protein: Insights into Folding and Misfolding from the Analysis of the Change in the Stabilization Energy Distribution in Different Conditions, 698 -707. In Proteins Structure Function And Bioinformatics 707 (April 2004).

Joel C Watts, Aru Balachandran, David Westaway (2006) The Expanding Universe of Prion Diseases. In PLoS Pathogens 2 (3).

Cellular Neurobiology Laboratory, La Jolla, United States, Structural Biology Laboratory (2006) The formation of bioactive amyloid species by prion proteins in vitro and in cells. In Neuroscience Letters.

Marta Soldevila, Francesc Calafell, Jaume Bertranpetit (2006) The prion protein gene in humans revisited: Lessons from a worldwide resequencing study. In Genome Research.

Jeff Holly Claire Perks (2006) The Role of Insulin-Like Growth Factor Binding Proteins, 154-160. In Neuroendocrinology.

Martin Herbst, Erich E Wanker (2006) Therapeutic Approaches to Polyglutamine Diseases: Combating Protein Misfolding and Aggregation. In Current Pharmaceutical Design.

N Popovic, P Brundin (2006) Therapeutic potential of controlled drug delivery systems in neurodegenerative diseases. In Biomaterials.

Seong-wook Yun, Klaus-Peter Lesch, Rainald Mo, Manfred Gerlach, Michael A Klein, Peter Riederer (2006) Unaltered susceptibility to scrapie in serotonin transporter de cient mice ¨, 454-458. In Neurochemistry International.

Emeritus Professor, Veterinary Medicine, Private B S E Consultant, Marlyns Drive, Electron Microscopy (2006) Variant CJD (vCJD) and Bovine Spongiform Encephalopathy (BSE): 10 and 20 years on: part 2, 102-110. In Folia Neuropathologica.

N Sales (2006) What can we learn from the oral intake of prions by sheep?, 1-3. In Journal of Pathology, The.

Manuel Corato, Cristina Cereda, Emanuela Cova, Carlo Ferrarese, Mauro Ceroni (2006) Young-onset CJD: age and disease phenotype in variant and sporadic forms, 211-215. In Functional Neurology 21 (4).

European Commission (2005) (SCENIHR) Opinion on The Safety of Human-derived Products with regard to Variant Creutzfeldt-Jakob Disease. In Review Literature And Arts Of The Americas.

Nicole Picard-hagen, Catherine Viguie, Valerie Laroute, Pierre-Louis TOUTAIN, Olivier Andre (2005) ) and intracellular (6713 n, 1-8. In Blood.

Anatol Kontush (2005) : Acute-phase apolipoprotein with metal-binding activity, 129-137. In English.

I-hsuan Liu, Vladimir N Uversky, Larissa A Munishkina, Anthony L Fink, Willi Halfter, Gregory J Cole (2005) Agrin binds, 1320-1331. In Access 15 (12).

N V Todd, J Morrow, K Doh-ura, S Dealler, P Farling, M Duddy, N G Rainov (2005) Cerebroventricular infusion of pentosan polysulphate in human variant Creutzfeldt–Jakob disease, 394-396. In Reviews in Medical Virology.

Marco Gobbi, Laura Colombo, Michela Morbin, Giulia Mazzoleni, Marco Vanoni, Elena Del Favero, Laura Cantù, Daniel A Kirschner, Claudia Manzoni, Marten Beeg, Paolo Ceci, Paolo Ubezio (2005) Into disease- specific insoluble species PrPsc, 1-19. In Analytical Biochemistry.

Eric M Norstrom, James A Mastrianni (2005) The AGAAAAGA Palindrome in PrP Is Required to Generate a Productive PrP, 27236 -27243. In Molecular Biology 280 (29).

Michael Aschner, Adrian K West (2005) The role of MT in neurological disorders, 139-145. In Medicine.

Harry Schachter (2005) The search for glycan function: Fucosylation of the TGF- ␤ 1 receptor is required for receptor activation, 15721-15722. 102 (44).

Plas Gogerddan, United Kingdom, Veterinary Laboratories Agency, New Haw (2005) The use of non-prion biomarkers for the diagnosis of Transmissible Spongiform Encephalopathies in the live animal, 665-683. In Veterinary Research.

Margherita Capasso, Jade-ming Jeng, Marco Malavolta, Eugenio Mocchegiani, Stefano L Sensi (2005) Zinc dyshomeostasis: A key modulator of neuronal injury, 93-108. In Nitric Oxide.

Nature Publishing Group (2004) 238 © 2004, 238-243. In Group 431 (September).

Elena Elimova, Robert Kisilevsky, Walter A Szarek, John B Ancsin, The Syl, Molly Apps Research Center, Kingston General Hospital (2004) Amyloidogenesis recapitulated in cell culture: a peptide inhibitor provides direct evidence for the role of heparan sulfate and suggests a new treatment strategy. In The FASEB Journal.

Claudio Soto, Joaquin Castilla (2004) The controversial protein-only hypothesis of prion propagation, 63-67. In Neurodegeneration.

Adrian C Apetri, Krystyna Surewicz, Witold K Surewicz (2004) The Effect of Disease-associated Mutations on the Folding Pathway of Human Prion Protein*, 18008 -18014. In Molecular Biology 279 (17).

Neville Vassallo, Jochen Herms, Hans A Kretzschmar (2004) The Molecular Pathology of Prion Diseases, 15-19. 16 (04).

Updated March (2004) Updated March 2004, 1-3. In Office 948776 (258197).

Review Article (2004) Watson and Crick 50 years on. From double helix to pharmacogenomics, 150-165. In Anaesthesia.

Karim Tarik Adjou, Steve Simoneau, Nicole Sale, Jean-philippe Deslys, Corinne Ida Lasme (2003) A novel generation of heparan sulfate mimetics for the treatment of prion diseases `, 2595-2603. In Journal of General Virology.

Ram Sasisekharan, James R Myette (2003) The Sweet Science of Glycobiology. In American Scientist.

Alfredo Gorio, Elena Lesma, Laura Madaschi, Anna Maria, Di Giulio (2002) Co-administration of IGF-I and glycosaminoglycans greatly delays motor neurone disease and affects IGF-I expression in the wobbler mouse: a long-term study, 194-202. In Diabetes.

Martin M Ferguson, Mbchb Bds, Oral Medicine, Oral Surgery (2002) The persistent dry mouth, 259-265. In Continuing Medical Education 29 (4).

Peter Friedrich (2002) The Role of Dimerization in Prion Replication. In Biophysical Journal 82 (April).

Boon-seng Wong Shu, G Chen Monica, Zhiliang Xie, Tao Pan, Tong Liu, Ruliang Li, Pierluigi Gambetti, David R Brown (2001) Aberrant metal binding by prion protein in human prion disease, 1400-1408. In Journal of Neurochemistry.

Alan Dove (2001) The bittersweet promise of glycobiology. In October.

Caroline Gabus, Edmund Derrington, Pascal Leblanc, Jonas Chnaiderman, Daniel Marc, Pradip Nandi, Jean-luc Darlix (2001) The Prion Protein Has RNA Binding and Chaperoning Properties Characteristic of Nucleocapsid Protein NCp7 of HIV-1*, 19301-19309. In Molecular Biology 276 (22).

M S Barquero, A Marcos, C A Mclean, D H Small (2000) Altered glycosylation of acetylcholinesterase in lumbar cerebrospinal fluid of patients with Alzheimer's disease. In Annals of Neurology.

Jason M Tanzer, D M D Ph D Jill Livingston, Angela M Thompson (2000) The Microbiology of Primary Dental Caries, 1-42. In English.

Dawn Of, Cariologic Insight (2000) The Rocky Road, 1352-1355. In Journal of Dental Research.

Koji Yasojima, Claudia Schwab, Edith G Mcgeer, Patrick L Mcgeer (1999) Up-Regulated Production and Activation of the Complement System in Alzheimer’s Disease Brain, 927-936. In American Journal Of Pathology 154 (3).

Kenneth S Kilgore, Keith B Naylor, Elaine J Tanhehco, James L Park, Erin A Booth, Ruth A Washington, Benedict R Lucchesi (1998) The Semisynthetic Polysaccharide Pentosan Polysulfate Prevents Complement-Mediated Myocardial Injury in the Rabbit Perfused Heart 1, 987-994. In Pharmacology 285 (3).

Masato Hasegawa, R Anthony Crowther, Ross Jakes, Michel Goedert (1997) Alzheimer-like Changes in Microtubule-associated Protein Tau Induced by Sulfated Glycosaminoglycans, 33118 -33124. In Molecular Biology 272 (52).

(1994) 5. Diagnosis and therapy 5.1. In Enzyme.

NOBEL LECTURE (1976) Unconventional viruses and the origin and disappearance of kuru. In Medicine.

Aluminum adjuvant linked to gulf war syndrome induces motor neuron death in mice, 1-42. In Anxiety.

Achim Osswald E-science and information services: a missing link in the context of digital libraries. In Online Information Review.

Las Vegas Unexplained Cattle Deaths and the Emergence of a Transmissible Spongiform Encephalopathy (TSE) Epidemic in North America. In Science.

W W W Prion Com Www.prion2005.com.

Ken-ichiro Fukuchi, Michael Hart, Ling Li [Frontiers in Bioscience 3, d327-337, March 21, 98] ALZHEIMER’S DISEASE AND HEPARAN SULFATE PROTEOGLYCAN Ken-ichiro Fukuchi, Michael Hart, and Ling Li. In Journal of Neurochemistry.

Catherine Hayes The Effect of Non-Cariogenic Sweeteners on the Prevention of Dental Caries: A Review of the Evidence, 1106-1109. In Journal of Dental Education 65 (10).

Chad A Dickey, Adeela Kamal, Karen Lundgren, Natalia Klosak, Rachel M Bailey, Judith Dunmore, Peter Ash, Sareh Shoraka, Jelena Zlatkovic, Christopher B Eckman, Cam Patterson, Dennis W Dickson, N Stanley Nahman, JR Michael, Francis Burrows, Leonard Petrucelli The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins. In Medicine.

Andis Klegeris, Edith G Mcgeer, Patrick L Mcgeer Therapeutic approaches to in ammation in neurodegenerative disease, 351-357. In Current Opinion in Neurology.

Water and the biology of prions. In In Vivo.

Your Patients' Your Patients' Health.